Re: Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity (Prevedello DM et al. Surg Neurol 2006;65:S1:14-S1:21).
Wong
George K C
GK
Poon
Wayne W S
WW
D002536:Cerebral Arteries / Q000187:drug effects / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D006801:Humans; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D015203:Reproducibility of Results; D018401:Sample Size; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000503:physiopathology / Q000601:surgery; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use; D020301:Vasospasm, Intracranial / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology
D014665:Vasodilator Agents; D008278:Magnesium Sulfate